Protecting Free Vaccines Act
- Bill Number
- H.R. 5448
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-09-18: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Last Updated
- 2026-07-10T08:06:01Z
AI-Generated Summary
Purpose of the Legislation
The Protecting Free Vaccines Act (H.R. 5448) aims to guarantee that certain vaccines recommended by the Advisory Committee on Immunization Practices (ACIP)—an expert group at the Centers for Disease Control and Prevention (CDC) that advises on vaccine use—are covered at no cost to individuals under major U.S. health programs and private insurance. It focuses on vaccines with ACIP recommendations in place as of October 25, 2024, to protect access even if recommendations change later.
Key Provisions
- Coverage Requirements: Mandates no-cost coverage (no deductibles, copays, or other out-of-pocket costs) for specified immunizations, including updates approved by the Food and Drug Administration (FDA) through supplemental applications.
- Time Frame: Applies to plan years starting from the date of enactment through December 31, 2029 (or until January 1, 2030, depending on the program).
- Exception: Coverage does not apply if a vaccine is given too soon, based on minimum spacing rules already set by law for preventive services.
- Programs Affected:
- Private Insurance and Employer Plans: Amends the Public Health Service Act (PHSA), Employee Retirement Income Security Act (ERISA), and Internal Revenue Code (IRC) to require group and individual health plans to cover these vaccines without cost sharing.
- Medicare: Updates Part D (prescription drug coverage) to include vaccines even if an ACIP recommendation is revoked after October 25, 2024, reverting to the last valid recommendation before revocation.
- Medicaid: Adds these vaccines to mandatory covered services, including for pregnant individuals; adjusts the pediatric vaccine distribution program to ignore post-October 25, 2024, removals from ACIP schedules; and requires states offering benchmark plans to include this coverage.
- Children's Health Insurance Program (CHIP): Requires states to cover these vaccines for eligible children, regardless of the plan type chosen.
Significant Changes to Existing Law
- Expands existing no-cost preventive coverage rules (e.g., under the Affordable Care Act) to "lock in" ACIP recommendations from October 25, 2024, preventing future revocations from affecting coverage during the bill's time frame.
- Introduces protections against changes in ACIP guidance, such as revocations or schedule updates, by referencing pre-existing recommendations.
- For Medicaid and CHIP, overrides state flexibility in some benefit designs to ensure vaccine inclusion, while updating the Vaccines for Children program to maintain access to affected pediatric vaccines.
- Adds conforming amendments to align references across laws, ensuring consistency in enforcement.
Potential Impacts
- On Citizens: Increases access to free vaccines for millions, particularly low-income families (via Medicaid/CHIP), seniors (Medicare), and those with employer or individual insurance, potentially boosting immunization rates and reducing disease outbreaks.
- On Government Agencies: The CDC and FDA may see indirect effects from stabilized vaccine recommendations; states administering Medicaid/CHIP will need to adjust programs and reporting; the Department of Health and Human Services (HHS) will oversee compliance without new funding specified.
- On International Relations: Minimal direct impact, though it could indirectly support global health efforts by maintaining U.S. vaccination levels, which aids in controlling infectious diseases that cross borders.
- No explicit cost estimates are provided, but it may increase federal and state spending on Medicaid/CHIP while reducing uncompensated care from vaccine-preventable illnesses.
Main Stakeholders Affected
- Beneficiaries: Individuals enrolled in Medicare, Medicaid, CHIP, or private/group health plans, especially children, pregnant people, and those at risk for vaccine-preventable diseases.
- Health Insurers and Plans: Issuers and employers must provide no-cost coverage, potentially facing administrative adjustments but no new taxes or penalties outlined.
- Healthcare Providers: Doctors and clinics administering vaccines, particularly in pediatric and public programs, benefit from assured reimbursement.
- Government Entities: States (Medicaid/CHIP administration), federal agencies (CDC for ACIP, HHS for oversight, FDA for approvals), and Congress (via committee referrals to Energy and Commerce, Ways and Means, Education and Workforce).
- Vaccine Manufacturers: Pharmaceutical companies producing affected vaccines may see sustained demand due to guaranteed coverage.
Notable Legal, Constitutional, or Political Implications
- Legal: Strengthens preventive care mandates under the Affordable Care Act by adding time-limited protections against advisory changes, potentially setting precedent for "grandfathering" health recommendations. It avoids First Amendment issues by not compelling speech or beliefs, focusing on coverage access.
- Constitutional: Aligns with Congress's authority to regulate interstate commerce and spending for public health (e.g., via Social Security Act amendments), without raising federalism concerns as states retain some Medicaid flexibility outside benchmarks.
- Political: Responds to debates over vaccine policy changes, ensuring continuity amid potential shifts in expert advice; its temporary nature (sunsetting in 2030) allows future review, but could spark discussions on federal overreach into state health programs or insurance markets. No partisan endorsements are noted in the bill text.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (81)
Rep. Neal, Richard E. [D-MA-1], Rep. Scott, Robert C. "Bobby" [D-VA-3], Rep. Landsman, Greg [D-OH-1], Rep. Mullin, Kevin [D-CA-15], Rep. Matsui, Doris O. [D-CA-7], Rep. Auchincloss, Jake [D-MA-4], Rep. Castor, Kathy [D-FL-14], Rep. Carter, Troy A. [D-LA-2], Rep. Nadler, Jerrold [D-NY-12], Rep. Schakowsky, Janice D. [D-IL-9], Rep. Schrier, Kim [D-WA-8], Rep. Beatty, Joyce [D-OH-3], Rep. Whitesides, George [D-CA-27], Rep. Quigley, Mike [D-IL-5], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Elfreth, Sarah [D-MD-3], Rep. Larson, John B. [D-CT-1], Rep. Scanlon, Mary Gay [D-PA-5], Rep. Wasserman Schultz, Debbie [D-FL-25], Rep. Magaziner, Seth [D-RI-2], Rep. Thompson, Mike [D-CA-4], Rep. Tonko, Paul [D-NY-20], Rep. Sewell, Terri A. [D-AL-7], Rep. Clarke, Yvette D. [D-NY-9], Rep. Dingell, Debbie [D-MI-6], Rep. McClellan, Jennifer L. [D-VA-4], Rep. Ivey, Glenn [D-MD-4], Rep. Menendez, Robert [D-NJ-8], Rep. Davis, Danny K. [D-IL-7], Rep. Soto, Darren [D-FL-9], Rep. Cohen, Steve [D-TN-9], Rep. Budzinski, Nikki [D-IL-13], Rep. Torres, Ritchie [D-NY-15], Rep. Tlaib, Rashida [D-MI-12], Rep. Barragán, Nanette Diaz [D-CA-44], Rep. DelBene, Suzan K. [D-WA-1], Rep. Amo, Gabe [D-RI-1], Rep. Levin, Mike [D-CA-49], Rep. Bonamici, Suzanne [D-OR-1], Rep. Keating, William R. [D-MA-9], Rep. Hayes, Jahana [D-CT-5], Rep. Frankel, Lois [D-FL-22], Rep. Ocasio-Cortez, Alexandria [D-NY-14], Rep. Trahan, Lori [D-MA-3], Rep. Peters, Scott H. [D-CA-50], Rep. Deluzio, Christopher R. [D-PA-17], Rep. Friedman, Laura [D-CA-30], Rep. Dexter, Maxine [D-OR-3], Rep. Pettersen, Brittany [D-CO-7], Rep. Raskin, Jamie [D-MD-8] and 31 more
Recent Actions
- 2025-09-18: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-09-18: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-09-18: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-09-18: Introduced in House
- 2025-09-18: Introduced in House
Bill Versions
- Protecting Free Vaccines Act — issued 2025-09-18 — PDF (11 pages)